GPR161 and medulloblastoma: For instance, parents of neonates with a GPR161 variant can be reassured that absolute risks of medulloblastoma are very small and the increased risk may disappear after age 4 years (this will be reassuring if results are given for a 5year old) similar to SUFU and PTCH1 [3, 5, 6].